Flying in the age of coronavirus comes packed with uncertainty about the health status of fellow travelers. Now, Florida's Tampa International Airport is running a pilot program that offers on-the-spot COVID-19 tests for travelers.
With more than 120 people participating in the optional testing per day, Joe Lopano, Tampa International Airport CEO, said the program is showing promising results.
"We've had some customers who have tested positive and Baycare, the healthcare professionals, have a discussion with that passenger and tell them that they should not continue on their way and passengers have accepted it," Lopano told Cheddar.
The airport offers two tests, the $125 PCR nasal swab, which usually takes 3 to 4 days to yield results, and the $50 rapid Antigen test. The cost of both tests, Lopano said, can be covered by insurance companies if travelers provide a receipt from the airport.
Testing at the airport, according to Lopano, will not have much impact on overall travel time. In fact, those not checking a bag only need to account for an additional 30 minutes as a cushion, he added.
"It's immediate testing. Sometimes you have to wait in a short line. You'll get your results in 15 minutes, so it really is not a very time-consuming function and it's very convenient," Lopano said.
While other airports have implemented testing for specific destinations, Lopano said Tampa is the first to offer widespread testing for passengers on all flights arriving and departing. The pilot program is likely to continue running through the holiday season as the number of participants and customer satisfaction is assessed.
For Lopano, offering a testing site at the airport is not only maintaining passenger safety but can also help revitalize a struggling travel industry that is fighting to get customers off the ground.
"It's a high priority because we need to do whatever we can to create confidence in the travel experience and now that widespread testing is available, the technology is available, what better way to do that than right at the airport," he said.
YouTube will offer creators a way to rejoin the streaming platform if they were banned for violating COVID-19 and election misinformation policies that are no longer in effect.
Lukas Alpert of MarketWatch explores how networks, brands, and ad buyers absorb the shockwaves when late‑night show hosts are suddenly cut — and brought back.
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Scott Trench, host of the BiggerPockets Money Podcast, explores how recent rate cuts, high borrowing costs, and mortgage rates are reshaping U.S. real estate.
